Table 5 Non-adherence to endocrine therapy: main reasons for and period of discontinuation in 31 non-adherent patients

From: Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

 

Number (%)

Main reasons for discontinuation

 Without reporting complaints

11 (35.5)

 Intolerance, general discomfort and malaise

9 (29.0)

 Hot flushes

4 (12.9)

 Dermatologic symptoms/hair loss

3 (9.7)

 Visual disturbances

1 (3.2)

 Alcohol dependency or psychiatric disease

3 (9.7)

Period of discontinuation (year of therapy)

 First year

12 (38.7)

 Second year

6 (19.4)

 Third year

9 (29.0)

 Fourth year

3 (9.7)

 Fifth year

1 (3.2)